SHPG : Analysis & Opinions

  1. NPS Pharmaceuticals' Natpara Approved with Boxed Warning - Analyst ...

    January 27, 2015
    NPS Pharmaceuticals' (NPSP) Natpara gained FDA approval as an adjunct treatment to calcium and vitamin D to control hypocalcemia ...
  2. Shire's Elvanse Gets Positive Response for ADHD in Adults - Analyst ...

    January 26, 2015
    Shire plc (SHPG) recently announced that it has received a positive response from the European Decentralised Procedure for ...
  3. Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst ...

    January 23, 2015
    The EC has approved Sanofi's (SNY) Cerdelga for the treatment of certain adults suffering from Gaucher disease type I.
  4. Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst ...

    January 21, 2015
    Valeant Pharmaceuticals International, Inc. (VRX) announced that its wholly owned subsidiary, Bausch + Lomb, has received ...
  5. CytRx Relieved as FDA Lifts Partial Hold on Oncology Drug - Analyst ...

    January 21, 2015
    CytRx Corporation (CYTR) received good news when the FDA removed the partial clinical hold on its oncology candidate aldoxorubicin.
  6. Beating the Greece Scare: 3 Stock Picks - Analyst Blog

    January 21, 2015
    The political situation in Greece has put forward another challenge for the region's economy.
  7. Roche to Acquire French Biotechnology Company Trophos - Analyst ...

    January 19, 2015
    Roche (RHHBY) announced today that will acquire privately-held French biotechnology company Trophos.
  8. BioCryst's BCX4161 Recommended for Orphan Drug in EU - Analyst ...

    January 15, 2015
    BioCryst Pharmaceuticals, Inc. (BCRX) received a positive opinion regarding its application for orphan drug status for BCX4161 ...
  9. Stock Market News for January 13, 2015 - Market News

    January 13, 2015
    Markets ended in the red zone for the second-consecutive day on Monday as oil price slide continued to dent investor sentiment
  10. Shire to Acquire NPS Pharmaceuticals for $5.2B - Analyst Blog

    January 12, 2015
    In a move to further strengthen its rare disease portfolio, Shire plc (SHPG) announced that it will acquire NPS Pharmaceuticals, ...
  11. Can Q4 Earnings Season Stop the Oil Slide? - Ahead of Wall Street

    January 12, 2015
    With Q4 earnings season right around the corner, better-than-expected gains from companies based partly or mostly on lower ...
  12. Valeant Up on Better-than-Expected 2015 Outlook, Eyes Deals ...

    January 9, 2015
    Shares of Valeant Pharmaceuticals International, Inc. (VRX) jumped 6.2% after the company provided better-than-expected outlook ...
  13. UCB Initiates Phase III Psoriasis Study on Cimzia with Dermira ...

    January 9, 2015
    UCB S.A. (UCBJF) and Dermira finished dosing the first set of patients in a phase III development program on Cimzia for moderate-to-severe ...
  14. Infinity Pharmaceuticals Falls on Duvelisib Study Results - Analyst ...

    January 9, 2015
    Infinity Pharmaceuticals' (INFI) duvelisib failed to meet the primary endpoint in a phase II study conducted in moderate-to-severe ...
  15. Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst ...

    January 9, 2015
    Pacira Pharmaceuticals, Inc. (PCRX) provided its revenue estimates for fourth-quarter and full-year 2014, both of which were ...
  16. BioLineRx Finishes Dose-Escalation in Phase I BL-8040 Study - ...

    January 8, 2015
    BioLineRx Ltd. (BLRX) completed the dose-escalation stage in a phase I study on BL-8040 for the mobilization of stem cells.
  17. BioCryst Rises on Positive Ebola Candidate Results - Analyst ...

    December 26, 2014
    Shares of BioCryst Pharmaceuticals (BCRX) rallied 6.9% after the announcement of results from a study on its Ebola virus ...
  18. Vanda Gains Fanapt Rights from Novartis for the U.S. Region ...

    December 24, 2014
    Vanda Pharmaceuticals Inc. (VNDA) recently announced that it has reached a settlement agreement with Novartis AG (Novartis) ...
  19. Keryx (KERX) Launches Renal Drug Auryxia in the U.S. - Analyst ...

    December 23, 2014
    Keryx Biopharmaceuticals, Inc. (KERX) announced it has begun to ship Auryxia (ferric citrate) tablets to wholesalers in the ...
  20. NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst ...

    December 18, 2014
    A report from Bloomberg indicated that the Shire is considering a potential acquisition of the NPS Pharma.
  21. Will MedTech Gain from Republican Promises? - Industry Outlook

    December 4, 2014
    Will MedTech Gain from Republican Promises? - Industry Outlook
  22. Tech Stocks Underperform Following Apple's Flash Crash, Holiday ...

    December 1, 2014
  23. Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

    November 18, 2014
    Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
  24. These 4 Stocks Are Potentially Topping Out

    October 13, 2014
    The S&P 500 definitively broke below its 15 month trend channel, therefore many stocks are facing a similar scenario. Here ...
  25. Global Tensions and Fear - Ahead of Wall Street

    September 23, 2014
    The start of an expanded air campaign in the Iraq-Syria theater and weak data out of Europe provide the unsettling backdrop ...
  26. The Celtic Tiger Roars Once Again

    March 21, 2014
    Everyone is Irish on St. Paddy’s Day. However, investors may want to keep that going with regards to their portfolios. After ...
  27. Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook

    December 3, 2013
    Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
  28. Can Sanofi Investors Just Blame It On Rio?

    August 6, 2013
    Can Sanofi Investors Just Blame It On Rio? By Stephen D. Simpson, CFA Sanofi (NYSE: SNY) was supposed to be a relatively ...
  29. Shire Settles Patent Dispute - Analyst Blog

    September 12, 2012
    Shire LLC, a subsidiary of Shire plc (SHPG) recently announced that it has entered into a settlement agreement with Anchen ...
  30. Strong Quarter at Shire - Analyst Blog

    August 2, 2012
    Shire plc (SHPG) posted second-quarter 2012 earnings (excluding special items) of $1.68 per American Depositary Share (ADS), ...
  31. Biggest Healthcare Sector Movers, Including SHPG

    July 31, 2012
    After the morning's trading, the Nasdaq is trading up 0.4%, the S&P 500 remains relatively unchanged and the Dow is unchanged. ...
Trading Center